Vanishing white matter disease expression of truncated EIF2B5 activates induced stress response

被引:18
|
作者
Keefe, Matthew D. [1 ]
Soderholm, Haille E. [1 ]
Shih, Hung-Yu [1 ]
Stevenson, Tamara J. [1 ]
Glaittli, Kathryn A. [1 ]
Bowles, D. Miranda [1 ]
Scholl, Erika [1 ]
Colby, Samuel [2 ]
Merchant, Samer [2 ]
Hsu, Edward W. [2 ]
Bonkowsky, Joshua L. [1 ,3 ]
机构
[1] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT 84112 USA
[2] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA
[3] Primary Childrens Med Ctr, Brain & Spine Ctr, Salt Lake City, UT 84113 USA
来源
ELIFE | 2020年 / 9卷
基金
美国国家卫生研究院;
关键词
ONSET EIF2B-RELATED DISORDERS; NATURAL-HISTORY; TRANSLATION; LEUKOENCEPHALOPATHY; OLIGODENDROCYTES; PHENOTYPE; GENOTYPE;
D O I
10.7554/eLife.56319
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Vanishing white matter disease (VWM) is a severe leukodystrophy of the central nervous system caused by mutations in subunits of the eukaryotic initiation factor 2B complex (eIF2B). Current models only partially recapitulate key disease features, and pathophysiology is poorly understood. Through development and validation of zebrafish (Danio rerio) models of VWM, we demonstrate that zebrafish eif2b mutants phenocopy VWM, including impaired somatic growth, early lethality, effects on myelination, loss of oligodendrocyte precursor cells, increased apoptosis in the CNS, and impaired motor swimming behavior. Expression of human EIF2B2 in the zebrafish eif2b2 mutant rescues lethality and CNS apoptosis, demonstrating conservation of function between zebrafish and human. In the mutants, intron 12 retention leads to expression of a truncated eif2b5 transcript. Expression of the truncated eif2b5 in wild-type larva impairs motor behavior and activates the ISR, suggesting that a feed-forward mechanism in VWM is a significant component of disease pathophysiology.
引用
收藏
页数:27
相关论文
共 50 条
  • [1] Vanishing White Matter Disease with Mutations in EIF2B5 Gene
    Sharma, Suvasini
    Ajij, Mohemmed
    Singh, Varinder
    Aneja, Satinder
    INDIAN JOURNAL OF PEDIATRICS, 2015, 82 (01): : 93 - 95
  • [2] Vanishing White Matter Disease with Mutations in EIF2B5 Gene
    Suvasini Sharma
    Mohemmed Ajij
    Varinder Singh
    Satinder Aneja
    The Indian Journal of Pediatrics, 2015, 82 : 93 - 95
  • [3] Vanishing white matter disease, a rare leukodystrophy with mutation in the EIF2B5 gene
    Sinko, Gabriella
    Tompa, Marton
    Kiss, Zsuzsanna
    Kalman, Bernadette
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2024, 77 (5-6):
  • [4] Peripheral neuropathy in vanishing white matter disease with a novel EIF2B5 mutation
    Federico, A.
    Scali, O.
    Stromillo, M. L.
    Di Perri, C.
    Bianchi, S.
    Sicurelli, F.
    De Stefano, N.
    Malandrini, A.
    Dotti, M. T.
    NEUROLOGY, 2006, 67 (02) : 353 - 355
  • [5] Peripheral neuropathy in a case of vanishing white matter disease with a novel EIF2B5 mutation
    Di Perri, C
    Garnbelli, S
    Berti, G
    Scali, O
    Stromillo, ML
    Bianchi, S
    Sicurelli, F
    De Stefano, N
    Malandrini, A
    Dotti, MT
    Federico, A
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2006, 11 (02) : 187 - 187
  • [6] Late-onset vanishing white matter disease with compound heterozygous EIF2B5 gene mutations
    Lee, H. -N.
    Koh, S. -H.
    Lee, K. -Y.
    Ki, C. -S.
    Lee, Y. J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (03) : e42 - e43
  • [7] Adult-onset leukoencephalopathy with vanishing white matter with a missense mutation in EIF2B5
    Ohtake, H
    Shimohata, T
    Terajima, K
    Kimura, T
    Jo, R
    Kaseda, R
    Iizuka, O
    Takano, M
    Akaiwa, Y
    Goto, H
    Kobayashi, H
    Sugai, T
    Muratake, T
    Hosoki, T
    Shioiri, T
    Okamoto, K
    Onodera, O
    Tanaka, K
    Someya, T
    Nakada, T
    Tsuji, S
    NEUROLOGY, 2004, 62 (09) : 1601 - 1603
  • [8] Vanishing white matter disease with a novel EIF2B5 mutation: A 10-year follow-up
    Bektas, Gonca
    Yesil, Gozde
    Ozkan, Melis Ulak
    Yildiz, Edibe Pembegul
    Uzunhan, Tugce Aksu
    Caliskan, Mine
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2018, 171 : 190 - 193
  • [9] EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy
    Dietrich, J
    Lacagnina, M
    Gass, D
    Richfield, E
    Mayer-Pröschel, M
    Noble, M
    Torres, C
    Pröschel, C
    NATURE MEDICINE, 2005, 11 (03) : 277 - 283
  • [10] Glial pathology in a novel spontaneous mutant mouse of the Eif2b5 gene: a vanishing white matter disease model
    Terumitsu-Tsujita, Mika
    Kitaura, Hiroki
    Miura, Ikuo
    Kiyama, Yuji
    Goto, Fumiko
    Muraki, Yoshiko
    Ominato, Shiho
    Hara, Norikazu
    Simankova, Anna
    Bizen, Norihisa
    Kashiwagi, Kazuhiro
    Ito, Takuhiro
    Toyoshima, Yasuko
    Kakita, Akiyoshi
    Manabe, Toshiya
    Wakana, Shigeharu
    Takebayashi, Hirohide
    Igarashi, Hironaka
    JOURNAL OF NEUROCHEMISTRY, 2020, 154 (01) : 25 - 40